Lawmakers Offer Additional Incentives to Boost Antibiotic Development

Drug Industry Daily
A A
A new House bill aims to build on the success of the Generating Antibiotics Now (GAIN) Act by allowing drugmakers to submit less data for antibiotics and antifungals that affect limited patient populations.

To View This Article:

Login

Subscribe To Drug Industry Daily